C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

CUSIP: 12529R107

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
88,353,400
Total 13F shares
52,538,995
Share change
-2,025,201
Total reported value
$116,636,299
Put/Call ratio
56%
Price per share
$2.22
Number of holders
96
Value change
-$3,450,925
Number of buys
47
Number of sells
62

Quarterly Holders Quick Answers

What is CUSIP 12529R107?
CUSIP 12529R107 identifies CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) as of Q3 2025

As of 30 Sep 2025, C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,538,995 shares. The largest 10 holders included Lynx1 Capital Management LP, Soleus Capital Management, L.P., ORBIMED ADVISORS LLC, MORGAN STANLEY, WASATCH ADVISORS LP, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, SILVERARC CAPITAL MANAGEMENT, LLC, and BlackRock, Inc.. This page lists 96 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.